Gain Therapeutics, Inc. | Business Contracts

Amended and Restated Employment Agreement, by and between the Company and Matthias Alder, dated September 20, 2022 (Filed With SEC on September 20, 2022)

Description of Securities (Filed With SEC on March 25, 2022)

Form of Stock Option Agreement under the 2021 Inducement Plan (Filed With SEC on December 28, 2021)

Form of Indemnification Agreement for Officers and Directors(b) (Filed With SEC on March 10, 2021)

Transition Agreement, by and between the Company and Eric Richman, dated September 19, 2022 (Filed With SEC on September 20, 2022)

Executive Employment Agreement, effective as of October 15, 2021, between Gain Therapeutics, Inc. and Matthias Alder (Filed With SEC on March 25, 2022)

Gain Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (Filed With SEC on December 28, 2021)

Executive Employment Agreement, effective as of October 15, 2021, between Gain Therapeutics, Inc. and Matthias Alder (Filed With SEC on November 12, 2021)

Underwriting Agreement, effective as of March 17, 2021, by and among BTIG, LLC and Oppenheimer & Co. Inc. as representatives of the several underwriters named therein and the... (Filed With SEC on March 22, 2021)

Form of Underwriting Agreement (Filed With SEC on March 15, 2021)

2020 Omnibus Incentive Plan(b) (Filed With SEC on March 10, 2021)

Form of Specimen common stock certificate (Filed With SEC on March 10, 2021)

Minoryx Agreement between Minoryx Therapeutics, S.L. and GT Gain Therapeutics SA (Filed With SEC on February 19, 2021)

Form of Placement Agent Warrant (Filed With SEC on February 19, 2021)

Form of Exchange Agreement (Filed With SEC on February 19, 2021)

Executive Employment Agreement, effective as of November 2, 2020, between Gain Therapeutics, Inc. and Salvatore Calabrese(b) (Filed With SEC on February 19, 2021)

Consulting Agreement effective as of September 1, 2019, between GT Gain Therapeutics S.A. and Sal Calabrese (Filed With SEC on February 19, 2021)

Executive Employment Agreement, effective as of August 13, 2020, between Gain Therapeutics, Inc. and Manolo Bellotto(b) (Filed With SEC on February 19, 2021)

Executive Employment Agreement, effective as of July 20, 2020, between Gain Therapeutics, Inc. and Eric I. Richman(b) (Filed With SEC on February 19, 2021)

Investors Rights Agreement, dated as of July 20, 2020, by and among Gain Therapeutics, Inc. and certain holders of its capital stock (Filed With SEC on February 19, 2021)

Gain Therapeutics, Inc. (21)